Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.36%
1,040.69
-3.71
-0.36%
1,044.401,041.751,048.311,037.77
SIXC
Communications
SIXC
Communications
SIXC
-1.59%
560.36
-9.05
-1.59%
569.41569.41569.41558.54
SIXE
Energy
SIXE
Energy
SIXE
+1.71%
1,317.69
+22.18
+1.71%
1,295.511,294.951,321.871,289.74
SIXI
Industrials
SIXI
Industrials
SIXI
-1.27%
1,606.91
-20.60
-1.27%
1,627.511,623.211,627.281,603.21
SIXM
Financials
SIXM
Financials
SIXM
-2.49%
590.28
-15.10
-2.49%
605.38603.79603.79588.51
SIXR
Staples
SIXR
Staples
SIXR
+0.79%
827.98
+6.50
+0.79%
821.48822.07833.11819.99
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.68%
197.04
-1.35
-0.68%
198.39198.39199.10196.67
SIXT
Technology
SIXT
Technology
SIXT
-1.92%
2,618.20
-51.38
-1.92%
2,669.582,654.812,660.502,611.26
SIXU
Utilities
SIXU
Utilities
SIXU
+0.61%
924.66
+5.61
+0.61%
919.05920.79933.78918.70
SIXV
Health care
SIXV
Health care
SIXV
-1.71%
1,449.59
-25.17
-1.71%
1,474.761,475.771,475.771,447.42
SIXY
Discretionary
SIXY
Discretionary
SIXY
-2.87%
2,136.89
-63.11
-2.87%
2,200.002,191.332,191.332,132.17
BAFNAPH:NSE
Bafna Pharmaceuticals Ltd
₹118.44
+0.61%
(+0.72) 1D
Mar 27, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BAFNAPH...
Open
₹120.07
High
₹123.60
Low
₹111.84
Mkt. cap
2.68B
Avg. vol.
4.07K
Volume
16.99K
P/E ratio
28.99
52-wk high
₹202.06
52-wk low
₹70.61
EPS
₹4.09
No. of employees
406
News stories
From sources across the web
About Bafna Pharmaceuticals Ltd
CEO-
Employees406
Founded1981
Headquarters-
SectorPharmaceutical industry
Last report
Feb 11, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -INR
Revenue / Estimate
382.86M/ (- est.)INR
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
390.60M
346.24M
354.68M
382.86M
Cost of goods sold
269.61M
224.18M
230.62M
272.68M
Cost of revenue
269.61M
224.18M
230.62M
272.68M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.56M
56.40M
54.90M
53.45M
Operating expense
86.89M
85.08M
95.97M
95.38M
Total operating expenses
356.50M
309.25M
326.59M
368.06M
Operating income
34.10M
36.99M
28.10M
14.80M
Other non operating income
-14.46M
5.96M
11.80M
12.19M
EBT including unusual items
13.11M
33.89M
31.25M
18.37M
EBT excluding unusual items
27.92M
33.89M
31.25M
18.37M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
23.00M
14.98M
26.34M
26.23M
Net income
13.11M
33.89M
31.25M
18.37M
Net profit margin
3.36%
9.79%
8.81%
4.80%
Earnings per share
-
-
-
-
Interest and investment income
1.36M
-
-
-
Interest expense
-6.53M
-9.05M
-8.64M
-8.62M
Net interest expenses
-5.17M
-9.05M
-8.64M
-8.62M
Depreciation and amortization charges
2.15M
13.70M
14.73M
15.70M
EBITDA
46.32M
49.21M
42.31M
27.02M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more